Cipla Limited Cipla Limited

Cipla Limited

CIPLA

Classement en actions #1814
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Prix de l'action
$14.61
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$11.81B
Changement (1 jour)
-0.11%
Changement (1 an)
-21.65%
Pays
IN
Échange Cipla Limited (CIPLA)

Catégorie

Healthcare
Historique des divisions d’actions pour Cipla Limited (CIPLA)
L’action Cipla Limited (symbole : CIPLA) a subi un total de 4 divisions.
La division la plus récente a eu lieu le Apr 24, 2006.
Une action CIPLA achetée avant le Oct 18, 1999 équivaudrait aujourd’hui à 112.5 actions CIPLA.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2006-04-24 5:2 x2.5 x112.5
2004-05-11 5:1 x5 x45
1999-10-21 3:1 x3 x9
1999-10-18 3:1 x3 x3
Divisions d’actions d’entreprises similaires ou concurrentes